A one-size-fits-all strategy is not the best approach for the development of a chemistry, manufacturing, and controls program.
Wayland Rushing
Advertisement
Wayland Rushing, PhD, is director, scientific affairs for Eurofins, BioPharma Product Testing.
Articles by Wayland Rushing
Advertisement
Latest Updated Articles
Designing Phase-Appropriate CMC Analytical ProgramsPublished: August 1st 2019 | Updated:
Advertisement
Advertisement
Trending on Pharmaceutical Technology
1
AAPS PharmSci 360 2025: Instrumentation Innovation for Bioanalysis
2
Using A Streamlined Workflow to Identify Particulates in Biologic Drugs
3
Using AI and Molecular Dynamics to Overcome the Poor Solubility Challenge
4
AI-Powered Digital Twins Achieve High Accuracy in Human Lung Function Forecasting
5
